Ligand validation:6I20

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 6I20 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6I20_FMN_B_401	96%	39%	0.063	0.969	1.25	1.13	5	3	0	0	100%	1
6I20_FMN_D_401	91%	44%	0.065	0.95	1.08	1.09	4	4	0	0	100%	0.9742
6I20_FMN_A_401	87%	36%	0.088	0.96	1.44	1.1	5	3	0	0	100%	0.9742
6I20_FMN_C_401	82%	33%	0.082	0.936	1.35	1.31	5	5	0	0	100%	0.9742
6I21_FMN_A_413	95%	21%	0.07	0.976	1.93	1.4	6	7	1	0	100%	0.3
6I22_FMN_A_401	89%	34%	0.082	0.96	1.33	1.26	4	4	1	0	100%	1
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	0.9677
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHH_FMN_A_401	100%	35%	0.026	0.994	1.4	1.19	5	5	0	0	100%	1
8J4W_FMN_C_201	100%	43%	0.031	0.992	1.08	1.12	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.